Zeyuan Yu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Prognostic Factors

Top Venues

Cancer research

Current cancer drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Zongrui Xing, Xiangyan Jiang, Yuxia Wu, Zeyuan Yu
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy. Current cancer drug targets 24 (9) (2024)
Zongrui Xing, Xiangyan Jiang, Yuxia Wu, Zeyuan Yu
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy. Current cancer drug targets (2024)
Wengui Shi, Lianshun Li, Huiming Zhao, Zhengyang Li, Zhijian Ma, Qianlin Gu, Huili Ye, Xiangyan Jiang, Yuman Dong, Long Qin, Huinian Zhou, Zeyuan Yu, Zuoyi Jiao
Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma. Cancer research (2024)
Huili Ye, Wengui Shi, Jing Yang, Long Wang, Xiangyan Jiang, Huiming Zhao, Long Qin, Juejie Qin, Lianshun Li, Weiwen Cai, Junhong Guan, Hanteng Yang, Huinian Zhou, Zeyuan Yu, Hui Sun, Zuoyi Jiao
PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer. Cancer research (2023)